Cite
HARVARD Citation
Manso, J. et al. (2022). Alemtuzumab‐induced autoimmune thyroid events in patients with relapsing‐remitting multiple sclerosis: A real‐life and monocentric experience at a tertiary‐level centre. Clinical endocrinology. pp. 331-338. [Online].